TransEnterix Inc. (TRXC)

0.97
AMEX : Commercial Services
Prev Close 1.00
Day Low/High 0.96 / 1.02
52 Wk Low/High 0.70 / 6.98
Avg Volume 2.38M
Exchange AMEX
Shares Outstanding 217.74M
Market Cap 217.72M
EPS -0.30
P/E Ratio N/A
Div & Yield N.A. (N.A)
TransEnterix Provides 2017 Year End Corporate Update

TransEnterix Provides 2017 Year End Corporate Update

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today provided a year-end corporate update.

TransEnterix To Present At The 36th Annual J. P. Morgan Healthcare Conference

TransEnterix To Present At The 36th Annual J. P. Morgan Healthcare Conference

TransEnterix, Inc. (NYSE American: TRXC) announced today that Todd M.

TransEnterix Announces Global SurgiBot System Agreement

TransEnterix Announces Global SurgiBot System Agreement

TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced that the Company has entered into an agreement with Great...

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CTHR, MOMO, SMIT, SPKE, TESS Downgrades: DCO, HTA, IMH, OPNT Initiations: TRXC Read on to get TheStreet Quant Ratings' detailed report:

TransEnterix Announces Senhance US Sale Agreement With Florida Hospital

TransEnterix Announces Senhance US Sale Agreement With Florida Hospital

TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced that Florida Hospital entered into an agreement to purchase...

TransEnterix, Inc. Reports Operating Results For The Third Quarter 2017

TransEnterix, Inc. Reports Operating Results For The Third Quarter 2017

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced its operating and financial results for the third quarter of...

TransEnterix To Feature Senhance™ Surgical System At AAGL: Advancing Minimally Invasive Gynecology Worldwide

TransEnterix To Feature Senhance™ Surgical System At AAGL: Advancing Minimally Invasive Gynecology Worldwide

TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced that it will exhibit and feature the Senhance™ Surgical...

TransEnterix To Present At The Stifel 2017 Healthcare Conference

TransEnterix To Present At The Stifel 2017 Healthcare Conference

TransEnterix, Inc. (NYSE MKT:TRXC) announced today that Todd M.

Interesting TRXC Put And Call Options For December 15th

Interesting TRXC Put And Call Options For December 15th

Investors in TransEnterix Inc saw new options become available today, for the December 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TRXC options chain for the new December 15th contracts and identified one put and one call contract of particular interest.

TransEnterix Schedules Third Quarter 2017 Financial And Operating Results Conference Call For November 9, 2017

TransEnterix Schedules Third Quarter 2017 Financial And Operating Results Conference Call For November 9, 2017

TransEnterix, Inc. (NYSE American:TRXC) announced today that it plans to release third quarter 2017 financial and operating results after the market closes on Thursday, November 9, 2017.

TransEnterix Announces US 510(k) FDA Clearance For Senhance Surgical Robotic System

TransEnterix Announces US 510(k) FDA Clearance For Senhance Surgical Robotic System

TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced the Company has received FDA 510(k) clearance for the...

TransEnterix Announces Dismissal Of Federal Securities Class Action

TransEnterix Announces Dismissal Of Federal Securities Class Action

TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced that the United States District Court for the Eastern District...

November 17th Options Now Available For TransEnterix (TRXC)

November 17th Options Now Available For TransEnterix (TRXC)

Investors in TransEnterix Inc saw new options begin trading today, for the November 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TRXC options chain for the new November 17th contracts and identified the following call contract of particular interest.

TransEnterix, Inc. Reports Progress On Senhance FDA Submission

TransEnterix, Inc. Reports Progress On Senhance FDA Submission

TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced the Company has filed its response to the Food and Drug...

TransEnterix To Participate In Two Upcoming Healthcare Conferences

TransEnterix To Participate In Two Upcoming Healthcare Conferences

TransEnterix, Inc. (NYSE American: TRXC) announced today that Joseph P.

TransEnterix Announces First Senhance U.S. Innovation Center At Florida Hospital Orlando

TransEnterix Announces First Senhance U.S. Innovation Center At Florida Hospital Orlando

TransEnterix, Inc. (NYSE MKT: TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced that it has installed a Senhance Surgical Robot at the Institute...

TransEnterix, Inc. Reports Operating Results For The Second Quarter 2017

TransEnterix, Inc. Reports Operating Results For The Second Quarter 2017

TransEnterix, Inc. (NYSE MKT:TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced its operating and financial results for the second quarter of 2017.

TransEnterix Announces Enhanced Capability To Perform Micro Incision Robotic Surgery

TransEnterix Announces Enhanced Capability To Perform Micro Incision Robotic Surgery

TransEnterix, Inc. (NYSE MKT: TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced that surgeons have now performed the first 3mm micro laparoscopic...

TransEnterix Schedules Second Quarter 2017 Financial And Operating Results Conference Call For August 2, 2017

TransEnterix Schedules Second Quarter 2017 Financial And Operating Results Conference Call For August 2, 2017

TransEnterix, Inc. (NYSE MKT: TRXC) announced today that it plans to release second quarter 2017 financial and operating results after the market closes on Wednesday, August 2, 2017.

TransEnterix Announces Sale Of Senhance™ Robotic Surgery System At Saitama Medical University International Medical Center In Japan

TransEnterix, Inc. (NYSE MKT:TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced that the Company has sold a Senhance Robotic Surgery System to the...

TransEnterix, Inc. Reports Operating Results For The First Quarter 2017

TransEnterix, Inc. (NYSE MKT:TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced its operating and financial results for the first quarter of 2017.

TransEnterix, Inc. Announces Loan Agreement With Innovatus Capital Partners, LLC

TransEnterix, Inc. (NYSE MKT:TRXC) (the "Company"), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced that it has entered into a debt financing agreement...

TransEnterix Announces Pricing Of $24.9 Million Public Offering Of Common Stock And Warrants

TransEnterix, Inc. (NYSE MKT:TRXC) ("TransEnterix"), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, announced the pricing of its public offering of units, each...

TransEnterix Announces Proposed Public Offering Of Common Stock And Warrants

TransEnterix, Inc. (NYSE MKT:TRXC) ("TransEnterix"), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, announced that it intends to offer and sell units, each consisting...

TransEnterix Schedules First Quarter 2017 Financial And Operating Results Conference Call For May 10, 2017

TransEnterix, Inc. (NYSE MKT: TRXC) announced today that it plans to release first quarter 2017 financial and operating results after the market closes on Wednesday, May 10, 2017.

TransEnterix Announces The Senhance™ Expansion Into Robotic Hernia Repair

TransEnterix, Inc. (NYSE MKT: TRXC) ("TransEnterix"), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced that it has expanded the clinical adoption of the...

TransEnterix, Inc. Reports Operating Results For The Fourth Quarter And Full Year 2016

TransEnterix, Inc. (NYSE MKT:TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced its operating and financial results for the fourth quarter and full...

TransEnterix Completes Sale Of The Senhance™ Surgical System In Germany

TransEnterix, Inc. (NYSE MKT: TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced that the Company has launched commercial operations and completed...

TransEnterix To Present At The Cowen And Company 37th Annual Health Care Conference

TransEnterix, Inc. (NYSE MKT:TRXC) announced today that Todd M.

TransEnterix Schedules Fourth Quarter And Fiscal Year 2016 Financial And Operating Results Conference Call For March 6, 2017

TransEnterix, Inc. (NYSE MKT: TRXC) announced today that it plans to release fourth quarter and fiscal year 2016 financial and operating results after the market closes on Monday, March 6, 2017.

TheStreet Quant Rating: D- (Sell)